DD129006A5 - Verfahren zur herstellung von pyrimidinderivaten - Google Patents

Verfahren zur herstellung von pyrimidinderivaten

Info

Publication number
DD129006A5
DD129006A5 DD7600194848A DD19484876A DD129006A5 DD 129006 A5 DD129006 A5 DD 129006A5 DD 7600194848 A DD7600194848 A DD 7600194848A DD 19484876 A DD19484876 A DD 19484876A DD 129006 A5 DD129006 A5 DD 129006A5
Authority
DD
German Democratic Republic
Prior art keywords
pyrimidine derivatives
preparing pyrimidine
preparing
derivatives
pyrimidine
Prior art date
Application number
DD7600194848A
Other languages
English (en)
Inventor
Arthur Boller
Marco Cereghetti
Hanspeter Scherrer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1223575A external-priority patent/CH622548A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DD129006A5 publication Critical patent/DD129006A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3444Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD7600194848A 1975-09-19 1976-09-17 Verfahren zur herstellung von pyrimidinderivaten DD129006A5 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1223575A CH622548A5 (en) 1975-09-19 1975-09-19 Liquid-crystal mixtures
CH22176 1976-01-09
CH231776 1976-02-25
CH976176 1976-07-30

Publications (1)

Publication Number Publication Date
DD129006A5 true DD129006A5 (de) 1977-12-21

Family

ID=27427800

Family Applications (2)

Application Number Title Priority Date Filing Date
DD76203733A DD135624A5 (de) 1975-09-19 1976-09-17 Fluessigkristalline mischungen
DD7600194848A DD129006A5 (de) 1975-09-19 1976-09-17 Verfahren zur herstellung von pyrimidinderivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD76203733A DD135624A5 (de) 1975-09-19 1976-09-17 Fluessigkristalline mischungen

Country Status (14)

Country Link
US (1) US4062798A (de)
JP (1) JPS5239685A (de)
AT (1) AT356111B (de)
CA (1) CA1062713A (de)
DD (2) DD135624A5 (de)
DE (1) DE2641724C2 (de)
DK (1) DK422376A (de)
FR (1) FR2324636A1 (de)
GB (1) GB1510090A (de)
HK (1) HK2179A (de)
IL (1) IL50478A (de)
IT (1) IT1068298B (de)
NO (1) NO763188L (de)
SE (1) SE7610422L (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701750A (nl) * 1976-02-26 1977-08-30 Hoffmann La Roche Mengsels van vloeibare kristallen.
NL7801718A (nl) * 1977-03-18 1978-09-20 Hoffmann La Roche Optische actieve verbindingen.
DE2815860A1 (de) * 1977-04-15 1978-10-19 Hoffmann La Roche Fluessigkristalline mischungen
US4198130A (en) * 1977-06-03 1980-04-15 Hoffmann-La Roche Inc. Liquid crystal mixtures
US4253740A (en) * 1977-09-12 1981-03-03 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Liquid crystal materials and devices containing them
JPS5941983B2 (ja) * 1978-02-17 1984-10-11 大日本インキ化学工業株式会社 トランス(エカトリアル↓−エカトリアル)1,4↓−ジ置換シクロヘキサン誘導体
US4309539A (en) * 1978-03-13 1982-01-05 Hoffmann-La Roche Inc. Pyrimidine derivatives
DE2944905A1 (de) * 1978-12-13 1980-10-23 Werk Fernsehelektronik Veb Kristallin-fluessige substituierte 1,3-dioxane und diese enthaltende gemische
CA1120478A (en) * 1979-02-05 1982-03-23 Arthur Boller Cyclohexyl pyrimidines
DE3014912A1 (de) * 1979-05-15 1980-11-27 Werk Fernsehelektronik Veb Nematische fluessigkristalline 5-cyan- 2- eckige klammer auf 4-acyloxyphenyl eckige klammer zu -pyrimidine und diese enthaltende gemische
DE3063497D1 (en) * 1979-08-20 1983-07-07 Werk Fernsehelektronik Veb Nematic crystalline-liquid 5-alkyl-2-(4-acyloxyphenyl)-pyrimidines for opto-electronic arrangements and process for their preparation
US4364838A (en) * 1979-11-14 1982-12-21 Hoffmann-La Roche Inc. Liquid crystal mixtures
DE2951099A1 (de) * 1979-12-19 1981-06-25 Merck Patent Gmbh, 6100 Darmstadt Tetrahydrochinazoline, verfahren zu ihrer herstellung, diese enthaltende fluessigkristalline dielektrika und elektrooptisches anzeigeelement
CH645102A5 (de) * 1980-10-14 1984-09-14 Hoffmann La Roche Disubstituierte pyrimidine.
US4325830A (en) * 1980-12-24 1982-04-20 Timex Corporation Three ring dioxane liquid crystalline compounds
DE3201721A1 (de) * 1981-01-30 1982-08-19 F. Hoffmann-La Roche & Co. AG, 4002 Basel Disubstituierte aethane
US4452718A (en) * 1981-07-31 1984-06-05 Hoffmann-La Roche Inc. Pyridazines
CH651025A5 (de) * 1982-05-14 1985-08-30 Hoffmann La Roche Pyridazine und ihre verwendung als komponenten fluessigkristalliner gemische.
US4528114A (en) * 1981-12-18 1985-07-09 Hoffmann-La Roche Inc. Acetylenes
US5227484A (en) * 1982-01-14 1993-07-13 Merck Patent Gmbh Anisotropic compounds having nematic phase and liquid crystal mixtures
US4512636A (en) * 1982-06-15 1985-04-23 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdon Of Great Britian And Northern Ireland Of Whitehall Liquid crystal compounds
JPS5939876A (ja) * 1982-08-26 1984-03-05 Chisso Corp ピリミジン誘導体
GB2133004B (en) * 1982-11-04 1986-06-11 Ici Plc Process for the extraction of metal values and novel metal extractants
DE3465192D1 (en) * 1983-03-16 1987-09-10 Hoffmann La Roche Liquid crystal components having an alkenyl chain
JPS59216876A (ja) * 1983-05-24 1984-12-06 Chisso Corp フルオロピリミジン誘導体
US4581155A (en) * 1983-03-31 1986-04-08 Chisso Corporation Halogenopyrimidine derivatives
DE3315295A1 (de) * 1983-04-27 1984-10-31 Merck Patent Gmbh, 6100 Darmstadt Fluorhaltige pyrimidinderivate
JPS60146877A (ja) * 1984-01-11 1985-08-02 Chisso Corp 2―置換―6―(5―置換―2―ピリミジニル)ナフタリン
DE3401321A1 (de) * 1984-01-17 1985-07-25 Merck Patent Gmbh, 6100 Darmstadt Stickstoffhaltige heterocyclen
DE3404116A1 (de) * 1984-02-07 1985-08-08 Merck Patent Gmbh, 6100 Darmstadt Stickstoffhaltige heterocyclen
US4609485A (en) * 1984-02-17 1986-09-02 Chisso Corporation Bipyrimidinyl derivatives
JPS61152659A (ja) * 1984-12-27 1986-07-11 Chisso Corp 1,4−ジピリミジニルベンゼン誘導体
JPS61180775A (ja) * 1985-01-22 1986-08-13 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング ジヒドロアジン液晶化合物
JPS61197563A (ja) * 1985-02-27 1986-09-01 Chisso Corp トリフルオロメチルフエニル基をもつピリミジン誘導体
JPS61233689A (ja) * 1985-03-22 1986-10-17 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 複素環式ホウ素化合物
EP0195974B1 (de) * 1985-03-26 1989-11-29 F. Hoffmann-La Roche Ag Alkenylsubstituierte Phenylisothiocyanate und Benzonitrile
US4874546A (en) * 1985-05-15 1989-10-17 Chisso Corporation Phenylpyrimidinecarboxylate derivative
JPS61280489A (ja) * 1985-06-05 1986-12-11 Chisso Corp 新規液晶化合物
EP0289270B1 (de) * 1987-04-27 1994-12-14 Chisso Corporation Optisch aktive 2-Biphenylpyrimidinderivate und diese enthaltende Flüssigkristallmischungen
EP0317175B1 (de) * 1987-11-17 1993-09-22 Seiko Epson Corporation Pyrimidinderivate
DE3928267A1 (de) * 1989-08-26 1991-02-28 Merck Patent Gmbh 5-oxy-2-phenylpyrimidine und fluessigkristallines medium
DE4423098A1 (de) 1994-07-01 1996-01-04 Hoechst Ag Verwendung von Pyrimidingruppen enthaltenden konjugierten Verbindungen als Elektrolumineszenzmaterialien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1452826A (en) * 1973-10-17 1976-10-20 Secr Defence Liquid crystal compositions
GB1433130A (en) * 1972-11-09 1976-04-22 Secr Defence Substituted biphenyl and polyphenyl compounds and liquid crystal materials and devices containing them
DD107563A1 (de) * 1973-09-27 1974-08-05
CH617452A5 (de) * 1974-10-25 1980-05-30 Hoffmann La Roche

Also Published As

Publication number Publication date
HK2179A (en) 1979-01-19
ATA693276A (de) 1979-09-15
JPS5527056B2 (de) 1980-07-17
JPS5239685A (en) 1977-03-28
DE2641724C2 (de) 1982-07-01
IL50478A (en) 1980-01-31
AT356111B (de) 1980-04-10
CA1062713A (en) 1979-09-18
DD135624A5 (de) 1979-05-16
US4062798A (en) 1977-12-13
AU1771776A (en) 1978-03-23
FR2324636B1 (de) 1979-09-28
NO763188L (no) 1977-03-22
SE7610422L (sv) 1977-03-20
FR2324636A1 (fr) 1977-04-15
DK422376A (da) 1977-03-20
DE2641724A1 (de) 1977-03-24
IT1068298B (it) 1985-03-21
IL50478A0 (en) 1976-11-30
GB1510090A (en) 1978-05-10

Similar Documents

Publication Publication Date Title
DD129006A5 (de) Verfahren zur herstellung von pyrimidinderivaten
DD137107A5 (de) Verfahren zur herstellung von spiro-hydantoinderivaten
DD130857A5 (de) Verfahren zur herstellung von n-phosphonomethylglycintriestern
DD128812A5 (de) Verfahren zur herstellung von chinazolonderivaten
AT354447B (de) Verfahren zur herstellung von indolderivaten
DD134526A5 (de) Verfahren zur herstellung von alkyloxinderivaten der 7-aminothiazolylazetamidozephalosporansaeure
DD127966A5 (de) Verfahren zur herstellung von pyrrolidinderivaten
DD127900A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
DD138904A5 (de) Verfahren zur herstellung von prostanderivaten
DD129330A5 (de) Verfahren zur herstellung von antitumorsubstanzen
DD139256A5 (de) Verfahren zur herstellung von substituierten diaminoanthrachinonen
AT351187B (de) Verfahren zur herstellung von 7-dehydrochol- esterinderivaten
AT344147B (de) Verfahren zur herstellung von acylcyaniden
DD130576A5 (de) Verfahren zur herstellung von derivaten von 5-hydroxy-chininzarinchinon
DD130036A5 (de) Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen
DD129334A5 (de) Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten
DD137584A5 (de) Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten
DD135488A5 (de) Verfahren zur herstellung von pyridazinon-derivaten
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
DD132790A5 (de) Verfahren zur herstellung von uracilderivaten
DD131562A5 (de) Verfahren zur herstellung von 5-pregnen-derivaten
PT71741B (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
DD122961A5 (de) Verfahren zur herstellung von diphenylaether-derivaten
DD131028A5 (de) Verfahren zur herstellung von pregnan-derivaten
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten